ENSG
Market cap | $5.04B |
---|---|
Enterprise value | $6.51B |
Revenue | $3.853B |
---|---|
EBITDA | $337.642M |
Income | $218.382M |
Revenue Q/Q | 13.91% |
Revenue Y/Y | 20.44% |
P/E | 32.14 |
---|---|
Forward P/E | 23.45 |
EV/Sales | 1.69 |
EV/EBITDA | 19.29 |
EV/EBIT | 22.34 |
PEG | 1.31 |
Price/Sales | 1.31 |
P/FCF | 26.98 |
Price/Book | 3.38 |
Book/Share | 36.99 |
Cash/Share | 13.06 |
FCF yield | 3.71% |
Volume | 350.278k / 405.000 |
---|---|
Relative vol. | 864.88 × |
EPS | 3.89 |
---|---|
EPS Q/Q | 14.29% |
Est. EPS Q/Q | 11.34% |
Profit margin | 5.61% |
---|---|
Oper. margin | 6.82% |
Gross margin | 15.84% |
EBIT margin | 7.57% |
EBITDA margin | 8.76% |
Ret. on assets | 5.29% |
---|---|
Ret. on equity | 14.76% |
ROIC | 7.36% |
ROCE | 8.10% |
Debt/Equity | 1.80 |
---|---|
Net debt/EBITDA | 16.61 |
Current ratio | 1.53 |
Quick ratio | 1.53 |
Volatility | 1.74% |
---|---|
Beta | 0.72 |
RSI | 61.40 |
---|
Insider ownership | 3.70% |
---|---|
Inst. ownership | 93.22% |
Shares outst. | 56.923M |
---|---|
Shares float | 0.000 0.00% |
Short % of float | 5.01% |
Short ratio | 8.69 |
Dividend | $0.24 |
---|---|
Dividend yield | 0.19% |
Payout ratio | 6.11% |
Payment date | N/A |
Ex-dividend date | N/A |
Earnings date | 1 Aug 2024 |
Saturday, 20 April 2024
|
|
30 Cities With High Quality Nursing Homes in the US | |
Sunday, 19 November 2023
|
|
The Ensign Group, Inc.'s Stock Is Going Strong: Is the Market Following Fundamentals? | |
Wednesday, 25 October 2023
|
|
Ensign Group Inc Reports Q3 2023 Earnings and Raises 2023 Earnings Guidance | |
Friday, 13 October 2023
|
|
22 Highest Paying Countries for Caregivers | |
Sunday, 6 August 2023
|
|
Calculating The Intrinsic Value Of The Ensign Group, Inc. | |
Saturday, 29 July 2023
|
|
Q2 2023 Ensign Group Inc Earnings Call | |
Monday, 1 May 2023
|
|
What Is The Ensign Group, Inc.'s Share Price Doing? | |
Monday, 6 February 2023
|
|
Ensign Group Shares Down 2% Since Q4 Earnings Release | |
Wednesday, 11 January 2023
|
|
15 Biggest Nursing Home Companies in the US | |
Monday, 2 January 2023
|
|
Is The Ensign Group, Inc.'s Stock's Recent Performance Being Led By Its Attractive Financial Prospects? | |
Tuesday, 2 August 2022
|
|
The Ensign Group Q2 2022 Earnings Call Transcript | |
Wednesday, 6 July 2022
|
|
The Ensign Group Acquires Skilled Nursing Facility in Las Vegas, Nevada - Yahoo Finance | |
Saturday, 30 April 2022
|
|
The Ensign Group Q1 2022 Earnings Call Transcript | |
Thursday, 10 February 2022
|
|
The Ensign Group Q4 2021 Earnings Call Transcript | |
Wednesday, 9 February 2022
|
|
Ensign Group Q4 Earnings Surpass Estimates | |
The Ensign Group Reports Fourth Quarter and Fiscal Year 2021 Results; Issues 2022 Guidance - Yahoo Finance | |
Sunday, 19 December 2021
|
|
2 Stocks for the GARP Investor | |
Saturday, 27 November 2021
|
|
Top 10 Stock Picks of Benjamin Natter’s Kent Lake Capital | |
Wednesday, 24 November 2021
|
|
The Ensign Group to Present at the Stephens Nashville Investment Conference on December 2, 2021 - Yahoo Finance | |
Monday, 8 November 2021
|
|
Caretrust Reit Inc Q3 2021 Earnings Call Transcript | |
Friday, 29 October 2021
|
|
The Ensign Group, inc Q3 2021 Earnings Call Transcript | |
Thursday, 29 July 2021
|
|
The Ensign Group, inc Q2 2021 Earnings Call Transcript | |
Monday, 10 May 2021
|
|
Ensign Group , Wasatch Global’s 2nd-Best Q1 2021 Contributor | |
Friday, 30 April 2021
|
|
Ensign Group Inc Q1 2021 Earnings Call Transcript | |
Insider |
Trans.
Transaction
|
Total value |
---|---|---|
Chad Keetch CIO, EVP, and Secretary | Option 5 Jun 2024 | $489,226 |
Daren Shaw Director | Sale 15 May 2024 | $236,520 |
Ann Scott Blouin Director | Sale 7 May 2024 | $40,765 |
Daren Shaw Director | Option 15 Apr 2024 | $48,602 |
Beverly B. Wittekind Vice President and General Counsel | Sale 14 Mar 2024 | $1,216,500 |
Daren Shaw Director | Sale 15 Feb 2024 | $718,020 |
Christopher R. Christensen Executive Chairman | Sale 6 Feb 2024 | $13,062,600 |
Daren Shaw Director | Option 15 Dec 2023 | $43,560 |
Spencer Burton President and COO | Sale 14 Dec 2023 | $905,597 |
Daren Shaw Director | Sale 15 Nov 2023 | $211,560 |
Daren Shaw Director | Option 10 Oct 2023 | $43,560 |
Powered by
Robintrack.
Price target
Current $126.41
Average $69.75
Low $64
High $79
Dividends
Ex-dividend date | N/A | Frequency | Quarterly | Annual dividend | +4.49% |
---|---|---|---|---|---|
Next dividend | N/A | Dividend yield | 0.19% | Growth period | 7 years |
Last dividend date | Yield 3 years | 0.21% | Growth 3 years | +4.71% | |
Last dividend | Yield 5 years | 0.23% | Growth 5 years | +4.90% |
Insider | Age | Since | Compensation |
---|---|---|---|
Christopher Christensen (51) Co-Founder, Executive Chairman, and the Chairman of the Board since 2019 | 51 | 2019 | $6,311,710 |
Barry Port (45) Chief Executive Officer and Director since 2019 | 45 | 2019 | $5,982,520 |
Suzanne Snapper (46) Chief Financial Officer and Executive Vice President since 2019 | 46 | 2019 | $5,810,380 |
Barry R. Port (47) Pres, CEO, and Director | 47 | $5,247,491 | |
Suzanne D. Snapper (47) CFO, Exec. VP, and Director | 47 | $4,376,055 | |
Chad Keetch (42) Executive Vice President, Chief Investment Officer, and Secretary since 2019 | 42 | 2019 | $3,680,570 |
Spencer W. Burton (42) Pres, COO of Ensign Services, and Inc. | 42 | $3,524,411 | |
Spencer Burton (41) President and Chief Operating Officer since 2019 | 41 | 2019 | $2,965,130 |
Chad A. Keetch (43) Chief Investment Officer, Exec. VP, and Sec. | 43 | $2,878,144 | |
Daren Shaw (63) Independent Director since 2012 | 63 | 2012 | $317,771 |
Lee Daniels (63) Independent Director since 2013 | 63 | 2013 | $311,771 |
Ann Blouin (67) Independent Director since 2018 | 67 | 2018 | $311,771 |
Barry Smith (66) Independent Director since 2014 | 66 | 2014 | $311,271 |
Roy Edgar Christensen (87) Co-Founder and Chairman Emeritus | 87 | $100,000 | |
Roy Christensen (86) Chairman Emeritus since 2019 | 86 | 2019 | $100,000 |
Swati Abbott (56) Independent Director since 2020 | 56 | 2020 | |
Kevin Reese | |||
Beverly B. Wittekind (56) VP and Gen. Counsel | 56 |
skilled nursing/assisted living
- Health Care > Health Care Facilities
- Ensign Group Inc, 29222 Rancho Viejo Road, San Juan Capistrano 92675, United States
- 949 487 9500
- Investor relations
Dividends
Ex-dividend date | N/A | Frequency | Quarterly | Annual dividend | +4.49% |
---|---|---|---|---|---|
Next dividend | N/A | Dividend yield | 0.19% | Growth period | 7 years |
Last dividend date | Yield 3 years | 0.21% | Growth 3 years | +4.71% | |
Last dividend | Yield 5 years | 0.23% | Growth 5 years | +4.90% |
Quarterly EPS estimates
Profit margin
Debt to assets
Cash flow
Balance sheet
(in millions USD) | 31 Mar 2024 | 31 Dec 2023 | |||
---|---|---|---|---|---|
Current assets | |||||
Cash | $511.839 | $509.626 | |||
Short term investments | $14.459 | $17.229 | |||
Net receivables | $519.439 | $485.039 | |||
Inventory | |||||
Total current assets | $1,088.188 | $1,046.93 | |||
Long term investments | |||||
Property, plant & equipment | $2,922.584 | $2,847.201 | |||
Goodwill & intangible assets | $83.8 | $83.394 | |||
Total noncurrent assets | $3,220.222 | $3,130.611 | |||
Total investments | $14.459 | $17.229 | |||
Total assets | $4,308.41 | $4,177.541 | |||
Current liabilities | |||||
Accounts payable | $82.635 | $92.811 | |||
Deferred revenue | |||||
Short long term debt | $89.881 | $86.476 | |||
Total current liabilities | $709.721 | $734.747 | |||
Long term debt | $1,846.185 | $1,784.823 | |||
Total noncurrent liabilities | $2,015.222 | $1,945.477 | |||
Total debt | $1,936.066 | $1,871.299 | |||
Total liabilities | $2,724.943 | $2,680.224 | |||
Stockholders' equity | |||||
Retained earnings | $1,208.074 | $1,142.653 | |||
Other stockholder equity | |||||
Total stockholder equity | $1,577.901 | $1,491.865 |
(in millions USD) | 2023 | 2022 | ||
---|---|---|---|---|
Current assets | ||||
Cash | $509.626 | $316.27 | ||
Short term investments | $17.229 | $15.441 | ||
Net receivables | $485.039 | $408.432 | ||
Inventory | ||||
Total current assets | $1,046.93 | $781.125 | ||
Long term investments | ||||
Property, plant & equipment | $2,847.201 | $2,443.005 | ||
Goodwill & intangible assets | $83.394 | $83.306 | ||
Total noncurrent assets | $3,130.611 | $2,670.897 | ||
Total investments | $17.229 | $15.441 | ||
Total assets | $4,177.541 | $3,452.022 | ||
Current liabilities | ||||
Accounts payable | $92.811 | $77.087 | ||
Deferred revenue | ||||
Short long term debt | $86.476 | $69.679 | ||
Total current liabilities | $734.747 | $582.072 | ||
Long term debt | $1,784.823 | $1,504.382 | ||
Total noncurrent liabilities | $1,945.477 | $1,621.15 | ||
Total debt | $1,871.299 | $1,574.061 | ||
Total liabilities | $2,680.224 | $2,203.222 | ||
Stockholders' equity | ||||
Retained earnings | $1,142.653 | $946.339 | ||
Other stockholder equity | ||||
Total stockholder equity | $1,491.865 | $1,247.332 |
Income statement
(in millions USD) | 31 Mar 2024 | 31 Dec 2023 | |||
---|---|---|---|---|---|
Revenue | |||||
Total revenue | $1,010.172 | $980.378 | |||
Cost of revenue | $851.139 | $831.762 | |||
Gross profit | $159.033 | $148.616 | |||
Operating activities | |||||
Research & development | |||||
Selling, general & administrative | $57.158 | $106.557 | |||
Total operating expenses | $76.815 | $125.79 | |||
Operating income | $82.218 | $22.826 | |||
Income from continuing operations | |||||
EBIT | $91.437 | $33.154 | |||
Income tax expense | $20.638 | $9.459 | |||
Interest expense | $1.964 | $2.004 | |||
Net income | |||||
Net income | $68.835 | $21.691 | |||
Income (for common shares) | $68.835 | $21.691 |
(in millions USD) | 2023 | 2022 | ||
---|---|---|---|---|
Revenue | ||||
Total revenue | $3,729.355 | $3,025.468 | ||
Cost of revenue | $3,138.596 | $2,507.483 | ||
Gross profit | $590.759 | $517.985 | ||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $263.005 | $158.805 | ||
Total operating expenses | $335.392 | $221.16 | ||
Operating income | $255.367 | $296.825 | ||
Income from continuing operations | ||||
EBIT | $280.398 | $298.049 | ||
Income tax expense | $62.912 | $64.437 | ||
Interest expense | $8.087 | $8.931 | ||
Net income | ||||
Net income | $209.399 | $224.681 | ||
Income (for common shares) | $209.399 | $224.681 |
Cash flows
(in millions USD) | 31 Mar 2024 | 31 Dec 2023 | |||
---|---|---|---|---|---|
Net income | $68.835 | $21.691 | |||
Operating activities | |||||
Depreciation | $19.852 | $19.411 | |||
Business acquisitions & disposals | -$2.437 | $0.2 | |||
Stock-based compensation | $8.238 | $8.076 | |||
Total cash flows from operations | $35.312 | $85.269 | |||
Investing activities | |||||
Capital expenditures | -$29.437 | -$42.934 | |||
Investments | -$2.831 | -$2.219 | |||
Total cash flows from investing | -$34.655 | -$44.944 | |||
Financing activities | |||||
Dividends paid | -$3.396 | -$3.243 | |||
Sale and purchase of stock | $6.215 | $5.662 | |||
Net borrowings | -$0.975 | -$0.966 | |||
Total cash flows from financing | $1.556 | $1.431 | |||
Effect of exchange rate | |||||
Change in cash and equivalents | $2.213 | $41.756 |
(in millions USD) | 2023 | 2022 | ||
---|---|---|---|---|
Net income | $209.399 | $224.681 | ||
Operating activities | ||||
Depreciation | $73.257 | $62.848 | ||
Business acquisitions & disposals | $0.248 | -$7.77 | ||
Stock-based compensation | $30.767 | $22.72 | ||
Total cash flows from operations | $376.666 | $272.513 | ||
Investing activities | ||||
Capital expenditures | -$173.978 | -$172.281 | ||
Investments | -$9.781 | -$7.47 | ||
Total cash flows from investing | -$182.698 | -$186.182 | ||
Financing activities | ||||
Dividends paid | -$12.89 | -$12.168 | ||
Sale and purchase of stock | $16.44 | -$18.907 | ||
Net borrowings | -$3.902 | -$6.892 | ||
Total cash flows from financing | -$0.612 | -$32.262 | ||
Effect of exchange rate | ||||
Change in cash and equivalents | $193.356 | $54.069 |
Recent institutional transactions
Quarter | Shareholder | Change |
Shares owned
Shares
|
Value (in thousands USD) |
---|---|---|---|---|
2024 Q2 | Gamma Investing |
+21.90%
|
1,280 | $158,323 |
2024 Q2 | Park Place Capital Corp |
-2.36%
|
620 | $76,688 |
2024 Q1 | Blackrock |
-6.84%
|
9,346,407 | $1,162,879,970 |
2024 Q1 | Fmr |
+59.09%
|
1,156,854 | $143,935,853 |
2024 Q1 | P2 Capital Partners |
Opened
|
230,000 | $28,616,600 |
2024 Q1 | Van Berkom & Associates |
-14.20%
|
858,799 | $106,852 |
2024 Q1 | Envestnet Asset Management Inc |
+37.15%
|
349,183 | $43,445,379 |
2024 Q1 | Capital Research Global Investors |
-3.06%
|
2,540,155 | $316,046,085 |
2024 Q1 | Victory Capital Management Inc |
-25.77%
|
225,736 | $28,086,080 |
2024 Q1 | Invesco |
+24.36%
|
382,386 | $47,576,466 |
Institutional shareholders
Shareholder | Stake |
Shares owned
Shares
|
Value (in thousands USD) |
---|---|---|---|
Blackrock | 16.42% | 9,346,407 | |
Vanguard Group Inc | 11.09% | 6,311,704 | |
Wasatch Advisors L.P. | 8.80% | 5,007,008 | |
Capital Research Global Investors | 4.46% | 2,540,155 | |
Fuller & Thaler Asset Management, Inc | 4.34% | 2,470,406 | |
State Street Corp | 3.69% | 2,098,896 | |
Riverbridge Partners | 2.27% | 1,293,794 | |
Dimensional Fund Advisors L.P. | 2.26% | 1,286,664 | |
Crewe Advisors | 2.13% | 1,211,171 | |
Fmr | 2.03% | 1,156,854 |